Healthful Heart Herbal Tea Blend
A Herb Tea Blend of Black Cohosh, Red Clover, Hawthorne Berry, Uva Ursi, Burdock Root, and Buchu Leaf
| $5.19 | Pack of 24 bags VPT1707 | Retails for $6.90 |
Delicious, Healthy & Caffeine Free!
Discover the delicious taste and healthful benefits of 100% natural herbal tea from Vitamin PowerŪ. Carefully selected herbal tea blend individually wrapped to ensure fresh taste and aroma in 24 easy to brew bags per stay fresh package.
Valuable natural herbal blend developed for individuals following a cardiovascular health regimen.
Caffeine-Free. Contains: Red Clover, Hawthorne Berry, Uva Ursi, Burdock Root, Buchu Leaf and Black Cohosh.
Find Black Cohosh Supplements at a Featured Merchant (below)
Arrythmia Associated With Heart Attacks Linked to Higher Risk of Death
According to new research from Duke University Medical Center, heart attack patients who develop serious arrhythmia in connection with procedures to open blocked arteries face a significantly higher risk of death for several months after the procedure, when compared to similar patients who do not develop such complications.
Now medical experts are re-evaluating and re-assessing the importance and the impact of these episodes. Until recently, the medical community generally felt that an episode of arrhythmia (also known as fibrillation or tachycardia) didn't complicate outcomes much for patients with blocked arteries because fast and effective treatments usually get blood flowing properly again. This new study indicates that they've been wrong because they now know that an episode of ventricular fibrillation at any point significantly affects a patient's chance of a successful outcome.
Researchers examined the records of 5745 heart attack patients enrolled in an international study of heart attack patients scheduled to undergo catheterization and stenting procedures between 2004 and 2006. They tracked which patients experienced arrhythmia, when it occurred, and what happened to patients afterwards.
They found that almost 6 percent of the patients experienced at least one episode of sustained ventricular arrhythmia either before or after the procedure.
They found that ventricular fibrillation occurred in 329 of the patients in the study group. Twenty-five of them experienced fibrillation before catheterization, 180 experienced it during the procedure and 117 afterwards. Investigators found that those who experienced fibrillation at any point were 3 times more likely to die within the first three months after the procedure, when compared to those who did not have any arrhythmia.
Patients with larger heart attacks and who had less blood flow to the heart muscle were more likely than others to experience arrhythmias. A majority of the episodes occurred within two days of the PCI procedure.
This study is important because it has helped identify a specific subset of patients who may need extra time in the hospital under more intense monitoring in order to get them safely through that two-day period post-procedure when the vast majority of these arrhythmic episodes occur. Researchers say the chances of a serious episode of arrhythmia fall significantly after the initial 48 hours following catheterization.
